课题基金 / 基金详情

P3:VEGF Influences Keratinocyte-Immunocyte Interactions in Psoriasiform Dermatiti

P3:VEGF Influences Keratinocyte-Immunocyte Interactions in Psoriasiform Dermatiti
P3:VEGF 影响银屑病样皮炎的角质细胞-免疫细胞相互作用
批准号:
8319619
负责人:
Nicole Leanne Ward
金额:
$21.58万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2013-08-31

项目摘要

项目成果

Nicole Leanne Ward的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Psoriasis is a common, chronic skin disease characterized by recurrent erythematous skin plaques that exhibit epidermal hyperplasia, inflammatory cell accumulation, and abnormalities of the papillary dermal vasculature. Studies examining the role of vascular specific growth factors have shown that members of the vascular endothelial growth factor (VEGF) and angiopoietin families contribute significantly to the development and maintenance of the psoriasis phenotype. We have engineered a line of mice that overexpress the angiopoietin tyrosine kinase receptor, Tie2 in keratinocytes (KCs), and our preliminary data suggests that these mice have a psoriasiform phenotype, including significant increases in endogenous VEGF, presence of acanthotic, erythematous skin, increased angiogenesis, and increased inflammatory cell infiltration, specifically neutrophils and myeloid/monocytic cells. We hypothesize that KC-specific tyrosine kinase receptor overexpression leads to KC proliferation, via increased VEGF expression and activation. This cutaneous change leads to increased angiogenesis, leaky vessels, and induction of the proinflammatory protein, S100A8/9, all of which enhance monocyte/myeloid cell recruitment, activation, and inflammation which maintain the psoriasiform phenotype. Using a combination of mouse molecular genetic approaches and function blocking antibodies, we will inhibit VEGF signaling, S100A8/A9 expression, or eliminate macrophages and determine the effects on the development and/or resolution of the phenotype. The information from these studies will provide further understanding about the roles, interactions, and significance of VEGF, S100A8/A9 and monocytic/myeloid cell activation in the development and maintenance of the psoriatic environment and could result in the identification of new therapeutic targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kallikrein-PAR interactions in skin inflammation
  • 批准号:
    10208722
  • 项目类别:
  • 资助金额:
    $25.54万
  • 财政年份:
    2018
  • 负责人:
    Nicole Leanne Ward
  • 依托单位:
Kallikrein-PAR interactions in skin inflammation
Kallikrein-PAR interactions in skin inflammation
Core 1: Pre-clinical Modeling Core
  • 批准号:
    10005123
  • 项目类别:
  • 资助金额:
    $31.62万
  • 财政年份:
    2017
  • 负责人:
    Nicole Leanne Ward
  • 依托单位:
海外基金